Healthcare & Pharmaceuticals

Published by
New York Times
|
By |
The Supreme Court ruled, in one of its most closely watched property rights cases in years, that fostering economic development is an appropriate use of the government's power of eminent domain. Read More
Published by
Boston Globe
|
By |
David Franklin, the drug company whistle-blower who has sparked federal and state investigations into the marketing of the top-selling drug Neurontin, said yesterday that he and his former colleagues engaged in a series of inappropriate tactics, including misleading doctors to persuade them to prescribe the drug for unapproved uses. Read More
Published by
Los Angeles Times
|
By |
Few industries campaigned harder than pharmaceutical manufacturers to elect Republicans to the new Congress, and few industries are better positioned to reap the rewards of the election returns, analysts said Thursday. Read More
Published by
Wired.com
|
By |
Many veterans' advocates believe a certain anthrax vaccine to be a major cause of Gulf War sickness. The company manufacturing it has launched a massive lobbying campaign to persuade the Bush administration to stockpile the controversial drug so it can be administered to civilians. Read More
Published by
OneWorld US
|
By |
AIDS activists are preparing rallies and demonstrations Thursday in several cities around the world to protest against global soft-drink giant Coca-Cola, which they charge must do more to help and treat its HIV-infected workers and their families in sub-Saharan Africa. Read More
Published by
AlterNet
|
By |
The HRT (Hormone Replacement Therapy) scandal is bigger than most think. It's not just about menopausal women, like me, getting bad information from their physicians and the pharmaceutical industry for over 40 years, while the federal government stood by and did nothing. The scandal is much bigger than that. Read More
Published by
Coalition Against Bayer Dangers
|
In Bayer and the Global Compact, Phillipp Mimkes of the Coalition Against Bayer Dangers looks at Bayer's corporate history and why it may be at odds with the Compact, a partnership between the UN and big business. Here, Mimkes offers a few more reasons. Read More
* indicates required